Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.700
0.00 (0.00%)
At close: Sep 17, 2026, 4:00 PM EDT
1.700
0.00 (0.00%)
After-hours: Sep 17, 2026, 4:00 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $72.85 million as of September 17, 2026. Its market cap has increased by 49.42% in one year.
Market Cap
72.85M
Enterprise Value
-14.99M
1-Year Change
49.42%
Ranking
Category
Stock Price
$1.70
ChartMarket Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $72.85M, a decrease of -69.02%. That is a compound annual growth rate of -26.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 72.85M | -4.20% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 75.88M |
| Kalaris Therapeutics | 75.70M |
| Gain Therapeutics | 75.07M |
| Pelthos Therapeutics | 74.35M |
| NeOnc Technologies Holdings | 74.32M |
| Cingulate | 74.02M |
| BioStem Technologies | 73.72M |
| Eloxx Pharmaceuticals | 71.16M |